Profilo
Lorne Taichman is Director, Science & Technology at Windham Venture Partners.
Lorne has an MD degree from the University of Toronto and a PhD in Molecular Biology from the University of Wisconsin.
Lorne is a professor emeritus at Stony Brook University where he directed a medical research laboratory for 30 years.
His field of study was stem cells and gene and cell therapy.
He has authored over 60 peer-reviewed publications and, in addition, was the recipient of an NIH MERIT award.
In 2000, Lorne spent a sabbatical year at Johnson & Johnson’s Corporate Office of Science and Technology where he evaluated emerging technologies.
Lorne remained a part-time consultant to COSAT and in 2007 he left the University to join Windham.
As Windham’s Director of Science & Technology, Lorne assists in locating new technologies for our review and in critically assessing the opportunity they present.
Posizioni attive di Lorne Taichman
| Società | Posizione | Inizio |
|---|---|---|
Windham Venture Management LLC
Windham Venture Management LLC Investment ManagersFinance Windham Venture Management invests in companies located in the United States. The firm targets companies operating in the fields of healthcare industries and sectors. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/01/2006 |
Formazione di Lorne Taichman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Windham Venture Management LLC
Windham Venture Management LLC Investment ManagersFinance Windham Venture Management invests in companies located in the United States. The firm targets companies operating in the fields of healthcare industries and sectors. It provides financing for early stage capital requirements. | Finance |
















